Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGSAVI in Essential Hypertension
NCT04686643Phase 3Unknown
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of s-amlodipine + valsartan + indapamide in essential hypertension, sponsored by Ahn-Gook Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
s-amlodipine + valsartan + indapamide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT04686643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686643.